Key result
Percutaneous femoral cannulation shows no significant difference in groin complications compared to surgical cut-down.
Why the study?
Femoral cannulation is essential in endoscopic minimally invasive heart valve surgery, but access-site outcomes, operative times, and 30-day morbidity needed comparison across surgical cut-down, suture-based, and plug-based percutaneous closure.
Does percutaneous femoral cannulation reduce intervention-requiring groin complications compared to surgical cut-down in patients undergoing endoscopic minimally invasive heart valve surgery?
Cohort (n=445)
No
Does percutaneous femoral cannulation reduce intervention-requiring groin complications compared to surgical cut-down in patients undergoing endoscopic minimally invasive heart valve surgery?
Percutaneous femoral cannulation is a safe alternative to surgical cut-down in appropriately selected patients undergoing minimally invasive heart valve surgery, offering shorter operative times and potentially fewer local wound complications.
Answers are grounded in this paper and cite their sources.
No significant difference in groin complications supports percutaneous access feasibility; leaves open randomized evaluation in endoscopic valve surgery.
Background/Objectives: Femoral cannulation is the cornerstone of endoscopic minimally invasive heart valve surgery (MICS). We compared three femoral access strategies—surgical cut-down, suture-based percutaneous closure (ProGlide®) and plug-based percutaneous closure (MANTA®)—for access-site outcomes, operative times and 30-day morbidity. Methods: This is a retrospective single-centre analysis of 445 consecutive patients undergoing endoscopic MICS (February 2021–May 2025). Access strategy (cut-down n = 119; ProGlide n = 219; MANTA n = 107) was selected by preoperative CT angiography and the surgeon’s discretion, with hostile anatomy triaged to cut-down. Baseline characteristics, intraoperative timing, primary haemostasis, conversion and 30-day outcomes were compared; a multivariable model within the percutaneous cohort adjusted for arterial cannula size and baseline covariates was used. Results: The mean age was 61.6 ± 11.3 years; 60.8% were male. EuroSCORE II was comparable between the percutaneous and cut-down groups (1.89 ± 2.55 vs. 2.03 ± 2.41; p = 0.594). Primary haemostasis was higher with MANTA than ProGlide (96.2% vs. 83.1%; p = 0.001; adjusted OR 4.79). Conversion to cut-down was similar (3.7% vs. 3.6%; p = 1.000). Intervention-requiring groin complications were fewer with percutaneous access (3.7% vs. 7.5%; p = 0.232). Cross-clamp, bypass and total operative times were shortest with MANTA (all p < 0.001). In-hospital mortality was 2.1% vs. 1.6% (p = 1.000). Conclusions: In appropriately selected patients, percutaneous femoral cannulation in MICS is safe and is associated with fewer groin complications and shorter operative times than cut-down. Within the percutaneous arm, MANTA was associated with a higher rate of primary haemostasis in our institutional experience. Cut-down remains indispensable for hostile femoral anatomy.
No takes yet. Share an insight, caveat, or question.
Ghazy et al. (2026) conducted a cohort in Endoscopic minimally invasive heart valve surgery (MICS) (n=445). Percutaneous femoral cannulation vs. Surgical cut-down was evaluated on Intervention-requiring groin complications (p=0.232). Percutaneous femoral cannulation resulted in a non-significant difference in intervention-requiring groin complications compared to surgical cut-down (3.7% vs 7.5%, p=0.232).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: